CompletedPhase 1NCT06111196
Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects
Studying Anorectal malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bio-Thera Solutions
- Principal Investigator
- Weiyong LiUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Intervention
- Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection(drug)
- Enrollment
- 59 target
- Eligibility
- 18-55 years · MALE
- Timeline
- 2023 – 2024
Study locations (1)
- Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology, Wuhan, Hubei, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06111196 on ClinicalTrials.govOther trials for Anorectal malformation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07441083Efficacy and Safety of Shatavari Root Extract in Women's Sexual WellnessSF Research Institute, Inc.
- RECRUITINGPHASE1NCT07545967Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After RadiotherapyWest China Hospital
- RECRUITINGNCT07438691Outcomes in ARMs: Comparison Between Surgical Techniques in Patients With Perineal or Vestibular Fistula - a Multicenter Italian StudyMeyer Children's Hospital IRCCS
- RECRUITINGNCT07174388A Study in Non-Small Cell Lung CancerN-Power Medicine
- RECRUITINGPHASE2NCT07311577Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical StudyJiangsu Cancer Institute & Hospital
- RECRUITINGPHASE2, PHASE3NCT07369739Golidocitinib Combined With Selinexor for CAEBVDBeijing Friendship Hospital
- RECRUITINGNANCT07263451Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory StudyTian'an Jiang
- RECRUITINGPHASE2NCT07447570Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCCSecond Affiliated Hospital, School of Medicine, Zhejiang University